{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:13:40Z","timestamp":1709424820926},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,2]]},"DOI":"10.7759\/cureus.55399","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:28:46Z","timestamp":1709396926000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperviscosity Syndrome in Undifferentiated Connective Tissue Disease: A Diagnostic and Therapeutic Challenge"],"prefix":"10.7759","author":[{"given":"Ian","family":"Mines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaq","family":"Al-Abayechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohra","family":"Nooruddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-06-846816","article-title":"Acute hyperviscosity: syndromes and management","volume":"132","author":"Gertz MA","year":"2018","unstructured":"Gertz MA. Acute hyperviscosity: syndromes and management. Blood. 2018, 132:1379-85. 10.1182\/blood-2018-06-846816","journal-title":"Blood"},{"key":"ref2","article-title":"Hyperviscosity syndrome in undifferentiated connective tissue disease: a case report","volume":"16","author":"Hasan A","year":"2021","unstructured":"Hasan A, Sharif S, Capric V, Ray M, Feoktistov A. Hyperviscosity syndrome in undifferentiated connective tissue disease: a case report. Int J Clin Rheumatol. 2021, 16:221-7.","journal-title":"Int J Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s100670200020","article-title":"Hyperviscosity syndrome in rheumatoid arthritis with Felty's syndrome: case report and review of the literature","volume":"21","author":"Zakzook SI","year":"2002","unstructured":"Zakzook SI, Yunus MB, Mulconrey DS. Hyperviscosity syndrome in rheumatoid arthritis with Felty's syndrome: case report and review of the literature. Clin Rheumatol. 2002, 21:82-5. 10.1007\/s100670200020","journal-title":"Clin Rheumatol"},{"key":"ref4","article-title":"Hyperviscosity syndrome","author":"Rogers AP","year":"2024","unstructured":"Rogers AP, Estes M. Hyperviscosity syndrome. StatPearls [Internet].  StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101503","article-title":"Clinical manifestations and treatment of antisynthetase syndrome","volume":"34","author":"Marco JL","year":"2020","unstructured":"Marco JL, Collins BF. Clinical manifestations and treatment of antisynthetase syndrome. Best Pract Res Clin Rheumatol. 2020, 34:101503. 10.1016\/j.berh.2020.101503","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome - much more than just a myopathy","volume":"51","author":"Opinc AH","year":"2021","unstructured":"Opinc AH, Makowska JS. Antisynthetase syndrome - much more than just a myopathy. Semin Arthritis Rheum. 2021, 51:72-83. 10.1016\/j.semarthrit.2020.09.020","journal-title":"Semin Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2397198320902667","article-title":"Antisynthetase syndrome: a distinct disease spectrum","volume":"5","author":"Huang K","year":"2020","unstructured":"Huang K, Aggarwal R. Antisynthetase syndrome: a distinct disease spectrum. J Scleroderma Relat Disord. 2020, 5:178-91. 10.1177\/2397198320902667","journal-title":"J Scleroderma Relat Disord"},{"key":"ref8","unstructured":"ABIM Laboratory Test Reference Ranges-January 2024. (2023). Accessed. 12\/17\/2023: https:\/\/www.abim.org\/Media\/bfijryql\/laboratory-reference-ranges.pdf."},{"key":"ref9","article-title":"Plasmapheresis in clinical medicine","volume":"138","author":"Linker C","year":"1983","unstructured":"Linker C. Plasmapheresis in clinical medicine. West J Med. 1983, 138:60-9.","journal-title":"West J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20302","article-title":"Conventional apheresis therapies: a review","volume":"26","author":"Ward DM","year":"2011","unstructured":"Ward DM. Conventional apheresis therapies: a review. J Clin Apher. 2011, 26:230-8. 10.1002\/jca.20302","journal-title":"J Clin Apher"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20247","article-title":"Introduction and overview of therapeutic apheresis","volume":"25","author":"Okafor C","year":"2010","unstructured":"Okafor C, Ward DM, Mokrzycki MH, Weinstein R, Clark P, Balogun RA. Introduction and overview of therapeutic apheresis. J Clin Apher. 2010, 25:240-9. 10.1002\/jca.20247","journal-title":"J Clin Apher"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-023-01099-5","article-title":"Undifferentiated connective tissue disease: comprehensive review","volume":"25","author":"Rubio J","year":"2023","unstructured":"Rubio J, Kyttaris VC. Undifferentiated connective tissue disease: comprehensive review. Curr Rheumatol Rep. 2023, 25:98-106. 10.1007\/s11926-023-01099-5","journal-title":"Curr Rheumatol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.42","article-title":"Treatment in myositis","volume":"14","author":"Oddis CV","year":"2018","unstructured":"Oddis CV, Aggarwal R. Treatment in myositis. Nat Rev Rheumatol. 2018, 14:279-89. 10.1038\/nrrheum.2018.42","journal-title":"Nat Rev Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000745","article-title":"Up-to-date treatment and management of myositis","volume":"32","author":"Pipitone N","year":"2020","unstructured":"Pipitone N, Salvarani C. Up-to-date treatment and management of myositis. Curr Opin Rheumatol. 2020, 32:523-7. 10.1097\/BOR.0000000000000745","journal-title":"Curr Opin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/199174-hyperviscosity-syndrome-in-undifferentiated-connective-tissue-disease-a-diagnostic-and-therapeutic-challenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:28:49Z","timestamp":1709396929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/199174-hyperviscosity-syndrome-in-undifferentiated-connective-tissue-disease-a-diagnostic-and-therapeutic-challenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.55399","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,2]]}}}